Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: A comparison of molecular and statistically estimated haplotypes

Pharmacogenetics and Genomics

Volumn 16, Issue 1, 2006, Pages 25-36

  Proudnikov, Dmitri ^a   LaForge, K Steven ^a   Hofflich, Heather ^a   Levenstien, Mark ^a   Gordon, Derek ^a   Barral, Sandra ^a   Ott, Jurg ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Heroin addiction; HTR1B; Human serotonin 1B receptor gene; Linkage disequilibrium; Molecular haplotype; Single nucleotide polymorphism; Statistically estimated haplotype

Indexed keywords

DIAMORPHINE; SEROTONIN 1B RECEPTOR;

AFRICAN AMERICAN; ARTICLE; BIODIVERSITY; CONTROLLED STUDY; DNA FLANKING REGION; ETHNOLOGY; FEMALE; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; UNITED STATES;

EID: 29144526846     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fpc.0000182782.87932.d6     Document Type: Article

References (78)

1. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999; 38:1083-1152.
2. Brunner D, Hen R. Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann NY Acad Sci 1997; 836:81-105.
3. Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L, et al. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 1994; 265:1875-1878.
4. Zhuang X, Gross C, Santarelli L, Compan V, Trillat AC, Hen R. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 1999; 21:52S-60S.
5. Malleret G, Hen R, Guillou JL, Segu L, Buhot MC. 5-HT1B receptor knockout mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J Neurosci 1999; 19:6157-6168.
6. Rocha BA, Scearce-Levie K, Lucas JJ, Hirol N, Castanon N, Crabbe JC, et al. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 1998; 393:175-178.
7. Crabbe JC, Phillips TJ, Feller DJ, Hen R, Wenger CD, Lessov CN, et al. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat Genet 1996; 14:98-101.
8. Parsons LH, Weiss F, Koob GF. Serotonini B receptor stimulation enhances cocaine reinforcement. J Neurosci 1998; 18:10078-10089.
9. Levitan RD, Kaplan AS, Masellis M, Basile VS, Walker ML, Lipson N, et al. Polymorphism of the serotonin 5HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biol Psychiatry 2001; 50:640-643.
10. Hawi Z, Dring M, Kirley A, Foley D, Kent L, Craddock N, et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT1B receptor gene in 273 nuclear families from a multi-centre sample. Mol Psychiatry 2002; 7:718-725.
11. New AS, Gelernter J, Goodman M, Mitropoulou V, Koenigsberg H, Silverman J, et al. Suicide, impulsive aggression, and HTR1B genotype. Biol Psychiatry 2001; 50:62-65.
12. Arango V, Huang Y, Underwood MD, Mann JJ. Genetics of the serotonergic system in suicidal behavior. J Psychiatric Research 2003; 37:375-386.
13. Sanders A, Cao Q, Taylor J, Levin TE, Badner JA, Cravchik A, et al. Genetic diversity of the human serotonin receptor 1B (HTR1B) gene. Genomics 2001; 72:1-14.
14. Huang YY, Oquendo MA, Friedman JMH, Greenhill LL, Brodsky B, Malone KM, et al. Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology 2003; 28:163-169.
15. Hasegawa Y, Higuchi S, Matsushita S, Miyaoka H. Association of a polymorphism of the serotonin 1B receptor gene and alcohol dependence with inactive aldehyde dehydrogenase-2. J Neural Transm 2002; 109:513-521.
16. Sun HFS, Chang YT, Fann CSJ, Chang CJC, Chen YH, Hsu YP, et al. Association study of novel human serotonin 5-HT1B polymorphisms with alcohol dependence in Taiwanese Han. Biol Psychiatry 2002; 51:896-901.
17. Nöthen MM, Erdmann J, Shimron-Abarbanell D, Propping P. Identification of genetic variation in the human serotonin 1Dβ receptor gene. Biochem Biophys Res Commun 1994; 205:1194-1200.
18. Gorwood P, Aissi F, Batel P, Ades J, Cohen-Salmon C, Hammon M, et al. Reappraisal of the serotonin 5-HT1B receptor gene in alcoholism: of mice and men. Brain Res Bull 2002; 57:103-107.
19. Lappalainen J, Long JC, Eggert M, Ozaki N, Robin RW, Brown GL, et al. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch Gen Psychiatry 1998; 55:989-994.
20. Nishiguchi N, Shirakawa O, Ono H, Nishimura A, Nushida H, Ueno Y, et al. No evidence of an association between 5HT1B receptor gene polymorphisms and suicide victims in Japanese population. Am J Med Genet 2001; 105:343-345.
21. Turecki G, Sequeira A, Gingras Y, Seguin M, Lesage A, Tousignant M, et al. Suicide and serotonin: Study of variation at seven serotonin receptor genes in suicide completers. Am J Med Genet 2003; 118B:36-40.
22. Huang YY, Grailhe R, Arango V, Hen R, Mann JJ. Relationship of psychopathology to the human serotonin 1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology 1999; 21:238-246.
23. Stefulj J, Büttner A, Skavic J, Zill P, Balija M, Eisenmenger W, et al. Serotonin 1B (5HT-1B) receptor polymorphism (G861C) in suicide victims: association studies in German and Slavic population. Am J Med Genet 2004; 127B:48-50.
24. Rujescu D, Giegling I, Sato T, Möller HJ. Lack of association between serotonin 5-HT1B receptor gene polymorphisms and suicidal behavior. Am J Med Genet 2003; 116B:69-71.
25. Nishiguchi N, Shirakawa O, Ono H, Nishimura A, Nushida H, Ueno Y, et al. Lack of an association between 5-HT1A receptor gene structural polymorphisms and suicide victims. Am J Med Genet 2002; 114:423-425.
26. Cigler T, LaForge KS, McHugh PF, Kapadia SU, Leal SM, Kreek MJ. Novel and previously reported single-nucleotide polymorphisms in the human 5HT1B receptor gene: no association with cocaine or alcohol abuse or dependence. Am J Med Genet 2001; 105:489-497.
27. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, et al. Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97:10483-10488.
28. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003; 12:205-216.
29. Brzustowicz LM, Merette C, Xie X, Townsend L, Gilliam TC, Ott J. Molecular and statistical approaches to the detection and correction in genotype databases. Am J Hum Genet 1993; 54:1137-1145.
30. Hoehe MR, Köpke K, Wendel B, Rohde K, Flachmeier C, Kidd KK, et al. Sequence variability and candidate gene analysis in complex disease: association of μ opioid receptor gene variation with substance dependence. Hum Mol Genet 2000; 9:2895-2908.
31. Proudnikov D, LaForge KS, Kreek MJ. High-throughput molecular haplotype analysis (allelic assignment) of single nucleotide polymorphisms by fluorescent polymerase chain reaction. Anal Biochem 2004; 335:165-167.
32. Witcombe D, Brownie J, Gillard HL, McKechnie D, Theaker J, Newton CR, et al. A homogeneous fluorescence assay for PCR amplification to real-time single-tube genotyping. Clin Chem 1998; 44:918-923.
33. Ranade K, Chang MS, Ting CT, Pei D, Hsiao CF, Oliver M, et al. High-throughput genotyping with single nucleotide polymorphisms. Genome Res 2001; 11:1262-1268.
34. Glaab WE, Skopek TR. A novel assay for allelic discrimination that combines the fluorogenic 5′ nuclease polymerase chain reaction (TaqMan) and mismatch amplification mutation assay. Mutat Res 1999; 430:1-12.
35. Tost J, Brandt O, Boussicault F, Debrala D, Caloustian C, Lechner D, et al. Molecular haplotyping at high throughput. Nucleic Acids Res 2002; 30:e96.
36. Ding C, Cantor CR. Direct molecular haplotyping of long-range genomic DNA with M1-PCR. Proc Natl Acad Sci USA 2003; 100:7449-7453.
37. Rettig RA, Yarmolinsky A, (eds). Federal regulation of methadone treatment. Washington, DC: National Academy of Sciences National Academy Press; 1995.
38. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association; 1994.
39. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treatm 1992; 9:199-213.
40. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
41. LaForge KS, Yuferov V, Kreek MJ. Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur J Pharmacol 2000; 410:249-268.
42. Nielsen DM, Ehm MG, Weir BS. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 1998; 63:1531-1540.
43. Abecasis GR, Cookson WO. GOLD - graphical overview of linkage disequilibrium. Bioinformatics 2000; 16:182-183.
44. Clayton D. SNPHAP: A program for estimating frequencies of large haplotypes of SNPs. 2002; http://www-gene.cimr.cam.ac.uk/clayton/software/
45. Gordon D, Yang Y, Haynes C, Finch SJ, Mendell NR, Brown AM, et al. Increasing power for tests of genetic association in the presence of phenotype and/or genotype error by use of double-sampling. Stat Appl Genet Mol Biol 2004; 3:Article 26. ftp://linkage.rockefeller.edu/software/lrtae
46. Ott J. Analysis of human genetic linkage. Baltimore: The Johns Hopkins University Press; 1999.
47. Ruano G, Kidd KK. Direct haplotyping of chromosomal segments from multiple heterozygotes via allele-specific PCR amplification. Nucleic Acids Res 1989; 17:8392.
48. Syvänen AC, Aalto-Setala K, Harju L, Kontula K, Soderlund H. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 1990; 8:684-692.
49. Sarkar G, Sommer SS. Haplotyping by double PCR amplification of specific alleles. BioTechniques 1991; 10:436-440.
50. Cha RS, Zarbl H, Keohavong P, Thilly WG. Mismatch amplification mutation assay (MAMA): application to the c-H-ras gene. PCR Methods and Applications 1992; 2:14-20.
51. Okimoto R, Dodgson JB. Improved PCR amplification of multiple specific alleles (PAMSA) using internally mismatched primers. BioTechniques 1996; 21:20-22.
52. Koss K, Fanning GC, Welsh KI, Jewell DP. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3′ mismatches in forward and reverse primers. Genes Immun 2000; 1:321-324.
53. Freeman GH, Halton JH. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951; 38:141-149.
54. Fisher RA. The design of experiments. Edinburgh: Oliver and Boyd; 1960.
55. Hill WG, Weir BS. Maximum-likelihood estimation of gene location by linkage disequilibrium. Am J Hum Genet 1994; 54:705-714.
56. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49:49-67.
57. Tenenbein A. A double sampling scheme for estimating from misclassified multinomial data with applications to sampling inspection. Technometrics 1972; 14:187-202.
58. Niu T. Algorithms for inferring haplotypes. Genet Epidemiol 2004; 27:334-347.
59. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296:2225-2229.
60. Edwards BJ, Haynes C, Levenstien MA, Finch SJ, Gordon D. Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies. BMC Genet 2005; 6:18.
61. Gordon D, Finch SJ, Nothnagel M, Ott J. Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum Hered 2002; 54:22-33.
62. Martinez-Arias R, Bertranpetit J, Comas D. Determination of haploid DNA sequences in humans: application to the glucocerebrosidase pseudogene. DNA Sequence 2002; 13:9-13.
63. Odeberg J, Holmberg K, Eriksson P, Uhlen M. Molecular haplotyping by pyrosequencing. BioTechniques 2002; 33:1104-1108.
64. Mitra RD, Butty VL, Shendure J, Williams BR, Housman DE, Church GM. Digital genotyping and haplotyping with polymerase colonies. Proc Natl Acad Sci USA 2003; 100:5926-5931.
65. Boldt AB, Petzl-Erler ML A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat 2002; 19:296-306.
66. McDonald OG, Krynetski EY, Evans WE. Molecular haplotyping of genomic DNA for multiple single-nucleotide polymorphisms located kilobases apart using long range polymerase chain reaction and intramolecular ligation. Pharmacogenetics 2002; 12:93-99.
67. Woolley AT, Guillemette C, Cheung CL, Housman DE, Lieber CM. Direct haplotyping of kilobase-size DNA using carbon nanotube probes. Nat Biotechnol 2000; 18:760-763.
68. Clark AG. Inference of haplotypes from PCR-amplified samples of diploid populations. Mol Biol Evol 1990; 7:111-122.
69. Terwilliger JD, Ott J. Handbook of human genetic linkage. Baltimore: Johns Hopkins; 1994.
70. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12:921-927.
71. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989.
72. Fallin D, Schork NJ. Accuracy in haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 2000; 67:947-959.
73. Matsuzaki H, Loi H, Dong S, Tsai YY, Fang J, Law J, et al. Parallel genotyping of over 10 000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res 2004; 14:414-425.
74. Duan J, Sanders AR, Molen JE, Martinolich L, Mowry BJ, Levinson DF, et al. Polymorphisms in the 5′-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression. Mol Psychiatry 2003; 8:901-910.
75. Arango V, Huang Y, Underwood MD, Mann JJ. Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res 2003; 37:375-386.
76. Duan S, Yin H, Chen W, Xing Q, Chen Q, Guo T, et al. No association between serotonin 1B receptor gene and schizophrenia in case-control and family-based association study. Neurosci Lett 2005; 376:93-97.
77. Tsai SJ, Wang YC, Chen JY, Hong CJ. Allelic variants of the tryptophan hydroxylase (A218C) and serotonin 1B receptor (A-161T) and personality traits. Neuropsychobiology 2003; 48:68-71.
78. Sinha R, Cloninger CR, Parsian A. Linkage disequilibrium and haplotype analysis between serotonin receptor 1B gene variations and subtypes of alcoholism. Am J Med Genet 2003; 121B:83-88.